深静脉血栓形成的治疗：哪些因素决定合适的治疗方法？
Treatment of deep vein thrombosis: what factors determine appropriate treatment?
作者信息
Douketis James D
机构信息
Department of Medicine, McMaster University, Hamilton, Ont.
出版信息
Can Fam Physician. 2005 Feb;51(2):217-23.
Abstract
OBJECTIVE
To identify patients with deep vein thrombosis (DVT) for whom in-hospital treatment should be considered.
QUALITY OF EVIDENCE
The literature was searched for studies on outpatient treatment of DVT. Seventeen studies were assessed: seven were randomized controlled trials (level I evidence), and 10 were non-randomized trials (level II evidence).
MAIN MESSAGE
Four criteria can be used to identify patients with DVT for whom outpatient treatment might not be appropriate: presence of massive DVT, presence of symptomatic pulmonary embolism, high risk of bleeding with anticoagulant therapy, and presence of comorbid conditions or other factors that warrant in-hospital care.
CONCLUSION
Four criteria can be used to identify patients with DVT for whom in-hospital treatment should be considered.
摘要
目的
确定那些应考虑进行住院治疗的深静脉血栓形成（DVT）患者。
证据质量
检索文献以查找有关DVT门诊治疗的研究。评估了17项研究：7项为随机对照试验（I级证据），10项为非随机试验（II级证据）。
主要信息
可使用四项标准来确定那些可能不适合门诊治疗的DVT患者：存在大面积DVT、存在症状性肺栓塞、抗凝治疗出血风险高，以及存在需要住院治疗的合并症或其他因素。
结论
可使用四项标准来确定那些应考虑进行住院治疗的DVT患者。
相似文献
1
Treatment of deep vein thrombosis: what factors determine appropriate treatment?
Can Fam Physician. 2005 Feb;51(2):217-23.
2
Eligibility for home treatment of deep vein thrombosis: a prospective study in 202 consecutive patients.
J Vasc Surg. 2001 Dec;34(6):1065-70. doi: 10.1067/mva.2001.118821.
3
Incidence, risk factors, and treatment patterns for deep venous thrombosis in hospitalized children: an increasing population at risk.
J Vasc Surg. 2008 Apr;47(4):837-43. doi: 10.1016/j.jvs.2007.11.054. Epub 2008 Mar 4.
4
Inconsistencies in the planning of the duration of anticoagulation among outpatients with acute deep-vein thrombosis. Results from the OTIS-DVT Registry.
Thromb Haemost. 2011 Feb;105(2):239-44. doi: 10.1160/TH10-08-0506. Epub 2010 Sep 30.
5
Inpatient and outpatient occurrence of deep vein thrombosis and pulmonary embolism and thromboprophylaxis following selected at-risk surgeries.
Ann Pharmacother. 2011 Sep;45(9):1045-52. doi: 10.1345/aph.1Q049. Epub 2011 Aug 23.
6
An open-label, comparative study of the efficacy and safety of once-daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep-vein thrombosis.
Thromb Res. 2004;114(3):149-53. doi: 10.1016/j.thromres.2004.05.009.
7
8
[Outpatient treatment of deep-vein thrombosis].
Ugeskr Laeger. 2007 Jan 8;169(2):112-5.
9
What is the optimal duration of treatment for DVT? An update on evidence-based medicine of treatment for DVT.
Semin Vasc Surg. 2010 Sep;23(3):182-91. doi: 10.1053/j.semvascsurg.2010.05.006.
10
Treatment of deep vein thrombosis.
Semin Vasc Med. 2001;1(1):43-54. doi: 10.1055/s-2001-14669.
引用本文的文献
1
Recurrent deep vein thrombosis following brown recluse spider bite complicated by medication noncompliance and residual scar tissue: A rare case report.
Clin Case Rep. 2023 Apr 25;11(4):e7263. doi: 10.1002/ccr3.7263. eCollection 2023 Apr.
2
A case of monoclonal gammopathy of undetermined significance and minimal change disease complicated by bilateral pulmonary emboli.
SAGE Open Med Case Rep. 2022 Aug 12;10:2050313X221117656. doi: 10.1177/2050313X221117656. eCollection 2022.
3
American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism.
Blood Adv. 2020 Oct 13;4(19):4693-4738. doi: 10.1182/bloodadvances.2020001830.
4
Massive Fatal Pulmonary Embolism While on Therapeutic Heparin Drip.
J Investig Med High Impact Case Rep. 2020 Jan-Dec;8:2324709620914787. doi: 10.1177/2324709620914787.
5
A retrospective analysis of outcomes in low- and intermediate-high-risk pulmonary embolism patients managed on an ambulatory medical unit in the UK.
ERJ Open Res. 2019 Apr 8;5(2). doi: 10.1183/23120541.00184-2018. eCollection 2019 Apr.
6
Management of venous thromboembolism: an update.
Thromb J. 2016 Oct 4;14(Suppl 1):23. doi: 10.1186/s12959-016-0107-z. eCollection 2016.
7
Direct-Acting Oral Anticoagulants: Practical Considerations for Emergency Medicine Physicians.
Emerg Med Int. 2016;2016:1781684. doi: 10.1155/2016/1781684. Epub 2016 May 16.
8
Ambulation after deep vein thrombosis: a systematic review.
Physiother Can. 2009 Summer;61(3):133-40. doi: 10.3138/physio.61.3.133. Epub 2009 Jul 16.
9
Nontreatment of deep vein thrombosis.
Can Fam Physician. 2005 May;51(5):654; author reply 654-5.
本文引用的文献
1
The outpatient treatment of deep vein thrombosis delivers cost savings to patients and their families, compared to inpatient therapy.
Thromb Res. 2003;112(1-2):13-8. doi: 10.1016/j.thromres.2003.09.027.
2
Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer.
N Engl J Med. 2003 Jul 10;349(2):146-53. doi: 10.1056/NEJMoa025313.
3
Comparison of 10-mg and 5-mg warfarin initiation nomograms together with low-molecular-weight heparin for outpatient treatment of acute venous thromboembolism. A randomized, double-blind, controlled trial.
Ann Intern Med. 2003 May 6;138(9):714-9. doi: 10.7326/0003-4819-138-9-200305060-00007.
4
Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies.
Arch Intern Med. 2002 Sep 9;162(16):1833-40. doi: 10.1001/archinte.162.16.1833.
5
Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology.
Arch Intern Med. 2002 May 27;162(10):1182-9. doi: 10.1001/archinte.162.10.1182.
6
Eligibility for home treatment of deep vein thrombosis: prospective study.
BMJ. 2001 May 19;322(7296):1212-3. doi: 10.1136/bmj.322.7296.1212.
7
Does the location of thrombosis determine the risk of disease recurrence in patients with proximal deep vein thrombosis?
Am J Med. 2001 May;110(7):515-9. doi: 10.1016/s0002-9343(01)00661-1.
8
Outpatient treatment of deep venous thrombosis in diverse inner-city patients.
Am J Med. 2001 Apr 15;110(6):458-62. doi: 10.1016/s0002-9343(01)00648-9.
9
Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease.
Ann Intern Med. 2001 Feb 6;134(3):191-202. doi: 10.7326/0003-4819-134-3-200102060-00009.
10
Antithrombotic therapy for venous thromboembolic disease.
Chest. 2001 Jan;119(1 Suppl):176S-193S. doi: 10.1378/chest.119.1_suppl.176s.
Zotero 插件